PRPH
ProPhase Labs, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.01
−3.75%Forward multiples
Based on analyst estimates
- P/E forward
- 0.00x
- P/E 2026E
- 0.00x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.01x
- Price / sales
- 0.01x
- Price / cash flow
- -0.00x
Enterprise value
- Enterprise value
- $9.1M
- EV / sales
- 2.89x
- EV / EBITDA
- -1.28x
- EV / EBIT
- -0.58x
- Market cap
- $32.0K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026